Literature DB >> 1282728

Effects of galanin on the secretory activity of the rat adrenal cortex: in vivo and in vitro studies.

G Mazzocchi1, L K Malendowicz, P Rebuffat, G G Nussdorfer.   

Abstract

Galanin, a 28-amino-acid peptide originally isolated from pig intestine, was found to cause dose-dependent rises in the plasma concentration of corticosterone in hypophysectomized rats and in both basal and submaximally ACTH-stimulated in vitro corticosterone production by adrenal quarters and isolated zona fasciculata/reticularis cells. These findings indicate that galanin exerts a direct glucocorticoid secretagogue effect on the inner adrenocortical zones and suggest that galanin, high concentrations of which are contained in adrenal chromaffin cells, may be included in that group of regulatory peptides, by way of which adrenal zona medullaris is thought to exert a paracrine control on the function of the zona corticalis. Galanin was also found to increase the plasma level of aldosterone in hypophysectomized rats in a dose-dependent manner without inducing changes in natremia, kalemia, plasma renin activity, or ACTH plasma concentration. Galanin did enhance both basal aldosterone output and that following submaximal ACTH or angiotensin II stimulation aldosterone output from adrenal quarters, but not from isolated zona glomerulosa cells. This last, rather unexpected, result suggests that galanin exerts an indirect mineralocorticoid secretagogue action, which seems to require the structural integrity of the adrenal cortex and the presence of the adrenal medulla. The hypothesis is advanced that galanin may control the release of some medullary peptides, which in turn may affect mineralocorticoid secretion of the zona glomerulosa in a paracrine manner.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282728     DOI: 10.1007/BF02576294

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  3 in total

1.  Interleukin-6-mediated signaling in adrenal medullary chromaffin cells.

Authors:  Danielle E Jenkins; Dharshini Sreenivasan; Fiona Carman; Babru Samal; Lee E Eiden; Stephen J Bunn
Journal:  J Neurochem       Date:  2016-12-05       Impact factor: 5.372

2.  Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.

Authors:  Paul G Unschuld; Marcus Ising; Darina Roeske; Angelika Erhardt; Michael Specht; Stefan Kloiber; Manfred Uhr; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

Review 3.  The evolving roles of alarin in physiological and disease conditions, and its future potential clinical implications.

Authors:  Endeshaw Chekol Abebe; Misganaw Asmamaw Mengstie; Mohammed Abdu Seid; Tabarak Malik; Tadesse Asmamaw Dejenie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.